Výsledky vyhledávání - "Sacristán, JA"

Akademický článek

Patient involvement in clinical research: why, when, and how

Autor: Sacristán JA, Aguarón A, Avendaño-Solá C, Garrido P, Carrión J, Gutiérrez A, Kroes R, Flores A

Publikováno v: Patient Preference and Adherence, Vol 2016, Iss Issue 1, Pp 631-640 (2016)

José A Sacristán,1 Alfonso Aguarón,2 Cristina Avendaño-Solá,3 Pilar Garrido,4 Juan Carrión,5 Alipio Gutiérrez,6 Robert Kroes,7 Angeles Flores11Medical Department, Lilly Spain, 2Myeloma Patients Europe, 3Research Ethics Committee, University Ho

Externí odkaz: https://doaj.org/article/83bd85e9e65a462ea17b9bce74e33a29

Zobrazit plný text záznamu

Akademický článek

Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population

Autor: Dilla T, Lizan L, Paz S, Garrido P, Avendaño C, Cruz-Hernández JJ, Espinosa J, Sacristán JA

Publikováno v: Patient Preference and Adherence, Vol 2016, Iss Issue 1, Pp 1-7 (2015)

Tatiana Dilla,1 Luís Lizan,2 Silvia Paz,2 Pilar Garrido,3 Cristina Avendaño,4 Juan J Cruz-Hernández,5 Javier Espinosa,6 José A Sacristán1 1Medical Department, Lilly, Madrid, 2Outcomes’10, Jaime I University, Castellón, 3Medical Oncology Depar

Externí odkaz: https://doaj.org/article/aa2dae8df5a047f8920d7a5126e5c9e7

Zobrazit plný text záznamu

Analysis of Orphan Drugs Marketed in Spain during the Period 2010- 2015: Epidemiological, Clinical and Economic Characteristics

Autor: Mercedes Núñez, Gil B, Tatiana Dilla, Sacristán Ja

Publikováno v: Health Economics & Outcome Research: Open Access.

Background: Since the adoption of the European law on orphan drugs in 2000, there has been a significant increase in the number of new therapies for the treatment of rare diseases. The present study aimed to analyse the evidence available on orphan d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::89568124e7d9a5af2b6b3ab4a6f22367
https://doi.org/10.4172/2471-268x.1000140

Zobrazit plný text záznamu

Service utilization and costs of first-onset schizophrenia in two widely differing health service areas in North-East Spain. PSICOST Group

Autor: Salvador-Carulla L, Haro JM, Cabasés J, Madoz V, Sacristán JA, Vázquez-Barquero JL

Publikováno v: ACTA PSYCHIATRICA SCANDINAVICA
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname

The aim of the study was to analyse the cost-incidence of schizophrenia in two areas with widely differing health service systems.The costs of patients with schizophrenia in the 3 years after the first service contact were evaluated (i) in an area (A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::16aa26c3c3473da8a97fb85cefff2ef1
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=15990

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání